Термин «воспалительные заболевания органов малого таза» (ВЗОМТ) объединяет весь спектр воспалительных процессов в области верхнего (выше внутреннего зева) отдела репродуктивного тракта у женщин. В структуре гинекологической заболеваемости ВЗОМТ занимают первое место – 60–65% амбулаторных больных и более 30% стационарных. Установить точную частоту и распространенность, а также диагностировать ВЗОМТ трудно в связи с частым отсутствием симптомов и разнообразием клинической картины. Проблемы лечения и реабилитации пациенток с ВЗОМТ остаются актуальными, так как рецидивы и хронизация воспалительных процессов значительно ухудшают прогноз в отношении репродуктивной функции, что является важной социальной и экономической проблемой.
The term "pelvic inflammatory disease" (PID) referred to an entire spectrum of inflammatory processes in the upper (above the internal os) part of female reproductive system. PID take the leading position in the structure of gynecological morbidity: 0–65% of outpatients and more than 30% of inpatients. It is difficult to determine the exact rate and prevalence of PID, as well as to diagnose PID because they often are asymptomatic or have diverts clinical manifestations. The issues of treatment and rehabilitation of patients with PID are still relevant, since cases of relapse and chronic inflammatory processes significantly worsen the prognosis for reproductive function, which is an important social and economic problem.
1. World Health Organization. Global Prevalence and Incidence of Selected Curable Sexually Transmitted Infections. Overview and Estimates. Geneva: WHO, 2010.
2. Sexually Transmitted Diseases Treatment Guidelines. MMWR Recommend Rep 2015; 64 (3): 78–82.
3. European Guideline for the Management of Pelvic Inflammatory Disease. http://www.iusti.org/regions/Europe/pdf/2015/PID_Treatment_Guidelines-Europe2015v5.pdf
4. Пестрикова Т.Ю., Юрасов И.В., Юрасова Е.А. Воспалительные заболевания в гинекологии. М.: Литтерра, 2009.
[Pestrikova T.Iu., Iurasov I.V., Iurasova E.A. Inflammatory diseases in gynecology. Moscow: Litterra, 2009 (in Russian).]
5. Rasmussen CB, Jensen A, Albieri V et al. Increased risk of borderline ovarian tumors in women with a history of pelvic inflammatory disease: A nationwide population-based cohort study. Gynecol Oncol 2016; 143 (2): 346–51.
6. Юрасов И.В. Современные аспекты тактики при воспалительных заболеваниях органов малого таза у женщин. Автореф. дис. ... д-ра мед. наук. Волгоград, 2015.
[Iurasov I.V. Sovremennye aspekty taktiki pri vospalitel'nykh zabolevaniiakh organov malogo taza u zhenshchin. Avtoref. dis. ... d-ra med. nauk. Volgograd, 2015 (in Russian).]
7. World Health Organization. Global Prevalence and Incidence of Selected Curable Sexually Transmitted Infections. Overview and Estimates. Geneva: WHO, 2001.
8. Хрянин А.А. Хронические воспалительные заболевания органов малого таза – стратегия достижения длительной ремиссии и рациональный подход к терапии. Medicine (Almaty) 2017; 1 (175).
[Khrianin A.A. Khronicheskie vospalitel'nye zabolevaniia organov malogo taza – strategiia dostizheniia dlitel'noi remissii i ratsional'nyi podkhod k terapii. Medicine (Almaty) 2017; 1 (175) (in Russian).]
9. Петерсен Э.Э. Инфекции в акушерстве и гинекологии. Пер. с англ. под общей ред. В.Н.Прилепской. М.: МЕДпресс-информ, 2007.
[Petersen E.E. Infections in obstetrics and gynecology. Ed. V.N. Prilepskaya. Moscow: MEDpress-inform, 2007 (in Russian).]
10. Ковалык В.П. Хламидийная инфекция в гинекологии: современные тренды патогенеза, диагностики и лечения. Гинекология. 2013; 15 (2): 42–7.
[Kovalyk V.P. Chlamydial infection in gynecology: the modern trends of the pathogenesis of diagnosis and treatment. Ginecology 2013; 15 (2): 42–7 (in Russian).]
11. Инфекции, передающиеся половым путем. Клинические лекции. Под ред. В.Н.Прилепской. М.: ГЭОТАР-Медиа, 2014.
[Sexually transmitted infections. Clinical lectures. Ed. V.N.Prilepskaya. Moscow: GEOTAR-Media, 2014 (in Russian).]
12. Шуршалина А.В. Воспалительные заболевания органов малого таза: современная тактика терапии. Гинекология. 2011; 13 (5): 23–6.
[Shurshalina A.V. Vospalitel'nye zabolevaniia organov malogo taza: sovremennaia taktika terapii. Ginekologiia. 2011; 13 (5): 23–6 (in Russian).]
13. Гинекология: национальное руководство. Под ред. Г.М.Савельевой, Г.Т.Сухих, В.Н.Серова и др. 2-е изд., перераб и доп.
М.: ГЭОТАР-Медиа, 2017.
[Gynecology: national leadership. Ed. G.M.Savelieva, G.T.Suhikh, V.N.Serov et al. 2nd ed. Moscow: GEOTAR-Media, 2017 (in Russian)]
14. Hryanin A.A., Reshetnikov O.V. Khlamidiinaya infekciya: ot nauki k praktike [Chlamydia infection: from science to practice]. Kiev: Publishing Ltd. Tetris-print, 2012; p. 180.
15. Амбулаторно-поликлиническая помощь в акушерстве и гинекологии. Практическое руководство. Под ред. И.С.Сидоровой, Т.В.Овсянниковой, И.О.Макарова. М.: МЕДпресс-информ, 2009.
[Outpatient care in obstetrics and gynecology. A practical guide. Ed. I.S.Sidorova, T.V.Ovsyannikova, I.O.Makarova. Moscow: MEDpress-inform, 2009 (in Russian).]
16. Озерская И.А. Эхография в гинекологии. М.: Медика, 2005.
[Ozerskaia I.A. Sonography in gynecology. Moscow: Medika, 2005 (in Russian).]
17. Буланов М.Н. Ультразвуковая гинекология. Курс лекций в 3 т.
Т. 3. М.: Видар, 2011.
[Bulanov M.N. Ultrasound Gynecology. Lecture course. V. 3. Moscow: Vidar, 2011 (in Russian).]
18. Кузьмин В.Н., Адамян Л.В., Пустовалов Д.А. Инфекции, передаваемые половым путем, и охрана репродуктивного здоровья женщин. М., 2010.
[Kuzmin V.N., Adamyan L.V., Pustovalov D.A. Sexually transmitted infections and women's reproductive health. Moscow, 2010 (in Russian).]
19. Jaiyeoba O, Jaiyeoba О, Lazenby G, Soper DE. Recommendations and rationale for the treatment of pelvic inflammatory disease. Expert Rev Anti Infect Ther 2011; 9 (1): 61–70.
20. Jaiyeoba O, Soper DE. A practical approach to the diagnosis of pelvic inflammatory disease. Infect Dis Obstet Gynecol 2011; 7 (5): 30–7.
21. Ross J, Judlin P, Jensen J et al. 2012 European guideline for the management of pelvic inflammatory disease. Int J STD AIDS 2014; 25 (1):
1–7.
22. Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015; 64 (RR-03): 1–137.
23. CDC. 2015 Sexually Transmitted Diseases Treatment Guidelines. Atlanta, GA: Department of Health and Human Services, 2015.
24. Женское здоровье. Руководство для врачей первичного звена. Под ред. А.Конолли, А.Бриттон. Пер. с англ. под общ. ред. В.Н.Прилепской. М.: МЕДпресс-информ, 2018.
[Women Health. A guide for primary care physicians. Ed. A.Conolly, A.Britton. General ed. V.N.Prilepskaya. Moscow: MEDpress-inform, 2018 (in Russian).]
25. Гомберг М.А. Новые Европейские рекомендации по ведению больных с хламидийной инфекцией: основные положения. Рос. вестн. акушера-гинеколога. 2011; 5: 102–6.
[Gomberg M.A. Novye Evropeiskie rekomendatsii po vedeniiu bol'nykh s khlamidiinoi infektsiei: osnovnye polozheniia. Ros. vestn. akushera-ginekologa. 2011; 5: 102–6 (in Russian).]
26. Пестрикова Т.Ю., Юрасова Е.А., Юрасов И.В. Медикаментозная терапия в практике врача акушера-гинеколога. М.: Литтерра, 2011.
[Pestrikova T.Iu., Iurasova E.A., Iurasov I.V. Drug therapy in the practice of an obstetrician-gynecologist. Moscow: Litterra, 2011 (in Russian).]
27. Стратегия и тактика рационального применения антимикробных средств в амбулаторной практике: европейские клинические рекомендации. Под ред. С.В.Яковлева, С.В.Сидоренко, В.В.Рафальского, Т.В.Спичак. М.: Пре100 Принт, 2016.
[Strategy and tactics of rational use of antimicrobial agents in outpatient practice: European clinical guidelines. Ed. S.V. Yakovleva, S.V. Sidorenko, V.V. Rafalsky, T.V. Spichak. Moscow: Pre100 Print, 2016 (in Russian).]
28. Козлов Р.С. Проблема антибиотикорезистентности в акушерстве и гинекологии. РМЖ. 2014; 1: 79–82.
[Kozlov R.S. Problema antibiotikorezistentnosti v akusherstve i ginekologii. RMZh. 2014; 1: 79–82 (in Russian).]
29. Chen PC, Tseng TС, Hsieh JY, Lin HW. Association between stroke and patients with pelvic inflammatory disease. Stroke 2011; 42: 2074–6.
30. Samra Z, Rosenberg S, Kaufman L. Antibiotic susceptibility of Ureaplasma urealyticum. In: The 2nd International Conference on the Macrolides, Azalides and Streptogramins. Venice, 1994.
31. Samra Z, Rosenberg S, Luzon A. In: The 3rd International Conference on the Macrolides, Azalides and Streptogramins. Lisbon, 1996.
32. Labro MT, Babin-Chevaye C. Synergistic interaction of josamycin with human neutrophils bactericidal function in vitro. J Antimicrob Chemother 1989; 24: 731–40.
33. Labro MT, Abdelghaffar H, Bryskier A. L-cladinose is involved in the antioxidant and degranulating effect of erythromycin A-derived macrolides. In: The 36th International Conference on Antimicribial Agents and Chemotherapy. New Orleans, 1996.
34. Labro MT, El Benna J, Abdelghaffar H. Modulation of human polymorphonuclear neutrophil function by macrolides: preliminary data concerning dirithromycin. J Antimicrob Chemother 1993; 31 (Suppl. C): 51–64.
35. Konno S, Asano K, Kurokawa M et al. Antiasthmatic activity of a macrolide antibiotic: analysis of possible mechanisms in vitro and in vivo. Int Arch Allergy Appl Immunol 1994; 105: 308–16.
36. Scaglione F, Rossini G. Comparative antiinflammatory effect of roxithromycin, azithromycin and clarithromycin. In: The 3rd International Conference on the Macrolides, Azalides and Streptogramins. Lisbon, 1996.
37. Herzog SA, Heijne JC et al. Describing the progression from Chlamydia trachomatis and Neisseria gonorrhoeae to pelvic inflammatory disease: systematic review of mathematical modeling studies. Althaus Sex Transm Dis 2012; 39 (8): 628–37.
38. Soper DE. Pelvic inflammatory disease. Obstet Gynecol 2010; 116 (6): 1459–60.
39. Shih TY, Gaydos CA, Rothman RE. Poor Provider Adberence to the Center s for Disease Control and Prevention Treatment Guidelines in US Emergency Department Visits Witb a Diagnosis of Pelvic Inflammatory Disease. Sex Trans Dis 2011; 38 (4): 299–305.
40. Pestrikova TYu, Yurasov IV, Yurasova EA. Inflammatory disease of the womans reproductive system: modern trends in diagnosis and therapy (literature review). Gynecology. 2018; 20 (6): 35–41. DOI: 10.26442/20795696.2018.6.180072
________________________________________________
1. World Health Organization. Global Prevalence and Incidence of Selected Curable Sexually Transmitted Infections. Overview and Estimates. Geneva: WHO, 2010.
2. Sexually Transmitted Diseases Treatment Guidelines. MMWR Recommend Rep 2015; 64 (3): 78–82.
3. European Guideline for the Management of Pelvic Inflammatory Disease. http://www.iusti.org/regions/Europe/pdf/2015/PID_Treatment_Guidelines-Europe2015v5.pdf
4. Pestrikova T.Iu., Iurasov I.V., Iurasova E.A. Inflammatory diseases in gynecology. Moscow: Litterra, 2009 (in Russian).
5. Rasmussen CB, Jensen A, Albieri V et al. Increased risk of borderline ovarian tumors in women with a history of pelvic inflammatory disease: A nationwide population-based cohort study. Gynecol Oncol 2016; 143 (2): 346–51.
6. Iurasov I.V. Sovremennye aspekty taktiki pri vospalitel'nykh zabolevaniiakh organov malogo taza u zhenshchin. Avtoref. dis. ... d-ra med. nauk. Volgograd, 2015 (in Russian).
7. World Health Organization. Global Prevalence and Incidence of Selected Curable Sexually Transmitted Infections. Overview and Estimates. Geneva: WHO, 2001.
8. Khrianin A.A. Khronicheskie vospalitel'nye zabolevaniia organov malogo taza – strategiia dostizheniia dlitel'noi remissii i ratsional'nyi podkhod k terapii. Medicine (Almaty) 2017; 1 (175) (in Russian).
9. Petersen E.E. Infections in obstetrics and gynecology. Ed. V.N. Prilepskaya. Moscow: MEDpress-inform, 2007 (in Russian).
10. Kovalyk V.P. Chlamydial infection in gynecology: the modern trends of the pathogenesis of diagnosis and treatment. Ginecology 2013; 15 (2): 42–7 (in Russian).
11. Sexually transmitted infections. Clinical lectures. Ed. V.N.Prilepskaya. Moscow: GEOTAR-Media, 2014 (in Russian).
12. Shurshalina A.V. Vospalitel'nye zabolevaniia organov malogo taza: sovremennaia taktika terapii. Ginekologiia. 2011; 13 (5): 23–6 (in Russian).
13. Gynecology: national leadership. Ed. G.M.Savelieva, G.T.Suhikh, V.N.Serov et al. 2nd ed. Moscow: GEOTAR-Media, 2017 (in Russian)
14. Hryanin A.A., Reshetnikov O.V. Khlamidiinaya infekciya: ot nauki k praktike [Chlamydia infection: from science to practice]. Kiev: Publishing Ltd. Tetris-print, 2012; p. 180.
15. Outpatient care in obstetrics and gynecology. A practical guide. Ed. I.S.Sidorova, T.V.Ovsyannikova, I.O.Makarova. Moscow: MEDpress-inform, 2009 (in Russian).
16. Ozerskaia I.A. Sonography in gynecology. Moscow: Medika, 2005 (in Russian).
17. Bulanov M.N. Ultrasound Gynecology. Lecture course. V. 3. Moscow: Vidar, 2011 (in Russian).
18. Kuzmin V.N., Adamyan L.V., Pustovalov D.A. Sexually transmitted infections and women's reproductive health. Moscow, 2010 (in Russian).
19. Jaiyeoba O, Jaiyeoba О, Lazenby G, Soper DE. Recommendations and rationale for the treatment of pelvic inflammatory disease. Expert Rev Anti Infect Ther 2011; 9 (1): 61–70.
20. Jaiyeoba O, Soper DE. A practical approach to the diagnosis of pelvic inflammatory disease. Infect Dis Obstet Gynecol 2011; 7 (5): 30–7.
21. Ross J, Judlin P, Jensen J et al. 2012 European guideline for the management of pelvic inflammatory disease. Int J STD AIDS 2014; 25 (1):
1–7.
22. Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015; 64 (RR-03): 1–137.
23. CDC. 2015 Sexually Transmitted Diseases Treatment Guidelines. Atlanta, GA: Department of Health and Human Services, 2015.
24. Women Health. A guide for primary care physicians. Ed. A.Conolly, A.Britton. General ed. V.N.Prilepskaya. Moscow: MEDpress-inform, 2018 (in Russian).
25. Gomberg M.A. Novye Evropeiskie rekomendatsii po vedeniiu bol'nykh s khlamidiinoi infektsiei: osnovnye polozheniia. Ros. vestn. akushera-ginekologa. 2011; 5: 102–6 (in Russian).
26. Pestrikova T.Iu., Iurasova E.A., Iurasov I.V. Drug therapy in the practice of an obstetrician-gynecologist. Moscow: Litterra, 2011 (in Russian).
27. Strategy and tactics of rational use of antimicrobial agents in outpatient practice: European clinical guidelines. Ed. S.V. Yakovleva, S.V. Sidorenko, V.V. Rafalsky, T.V. Spichak. Moscow: Pre100 Print, 2016 (in Russian).
28. Kozlov R.S. Problema antibiotikorezistentnosti v akusherstve i ginekologii. RMZh. 2014; 1: 79–82 (in Russian).
29. Chen PC, Tseng TС, Hsieh JY, Lin HW. Association between stroke and patients with pelvic inflammatory disease. Stroke 2011; 42: 2074–6.
30. Samra Z, Rosenberg S, Kaufman L. Antibiotic susceptibility of Ureaplasma urealyticum. In: The 2nd International Conference on the Macrolides, Azalides and Streptogramins. Venice, 1994.
31. Samra Z, Rosenberg S, Luzon A. In: The 3rd International Conference on the Macrolides, Azalides and Streptogramins. Lisbon, 1996.
32. Labro MT, Babin-Chevaye C. Synergistic interaction of josamycin with human neutrophils bactericidal function in vitro. J Antimicrob Chemother 1989; 24: 731–40.
33. Labro MT, Abdelghaffar H, Bryskier A. L-cladinose is involved in the antioxidant and degranulating effect of erythromycin A-derived macrolides. In: The 36th International Conference on Antimicribial Agents and Chemotherapy. New Orleans, 1996.
34. Labro MT, El Benna J, Abdelghaffar H. Modulation of human polymorphonuclear neutrophil function by macrolides: preliminary data concerning dirithromycin. J Antimicrob Chemother 1993; 31 (Suppl. C): 51–64.
35. Konno S, Asano K, Kurokawa M et al. Antiasthmatic activity of a macrolide antibiotic: analysis of possible mechanisms in vitro and in vivo. Int Arch Allergy Appl Immunol 1994; 105: 308–16.
36. Scaglione F, Rossini G. Comparative antiinflammatory effect of roxithromycin, azithromycin and clarithromycin. In: The 3rd International Conference on the Macrolides, Azalides and Streptogramins. Lisbon, 1996.
37. Herzog SA, Heijne JC et al. Describing the progression from Chlamydia trachomatis and Neisseria gonorrhoeae to pelvic inflammatory disease: systematic review of mathematical modeling studies. Althaus Sex Transm Dis 2012; 39 (8): 628–37.
38. Soper DE. Pelvic inflammatory disease. Obstet Gynecol 2010; 116 (6): 1459–60.
39. Shih TY, Gaydos CA, Rothman RE. Poor Provider Adberence to the Center s for Disease Control and Prevention Treatment Guidelines in US Emergency Department Visits Witb a Diagnosis of Pelvic Inflammatory Disease. Sex Trans Dis 2011; 38 (4): 299–305.
40. Pestrikova TYu, Yurasov IV, Yurasova EA. Inflammatory disease of the womans reproductive system: modern trends in diagnosis and therapy (literature review). Gynecology. 2018; 20 (6): 35–41. DOI: 10.26442/20795696.2018.6.180072
Авторы
Т.Н. Бебнева*1,2, К.Ф. Дамиров1
1. ФГАОУ ВО «Российский университет дружбы народов», Москва, Россия;
2. ФГБУ «Национальный медицинский исследовательский центр эндокринологии» Минздрава России, Москва, Россия
*bebn@mail.ru
________________________________________________
Tamara N. Bebneva*1,2, Kemer F. Damirov1
1. People’s Friendship University of Russia, Moscow, Russia;
2. Endocrinology Research Center, Moscow, Russia
*bebn@mail.ru